Hutchison China MediTech LtdHCM:LSE

7.50 / 0.66%
Latest price in GBXToday's changeShares traded1 year changeBeta
Data delayed at least 15 minutes, as of Oct 23 2014 12:49 BST.
HCM:LSE is traded on the London Stock Exchange Alternative Investment Market (Aim)


As of last trade Hutchison China MediTech Ltd (HCM:LSE) traded at 1,130, 8.87% below its 52-week high of 1,240, set on Sep 22, 2014.

52-week range
Nov 22 2013
Sep 22 2014
Day high--
Day low--
Previous close1,137.5
Average volume14.82k
Shares outstanding52.90m
Free float14.74m
P/E (TTM)131.72
Market cap603.91m GBP
EPS (TTM)0.0867 GBP
Last IC View
The last IC recommendation on Hutchison China MediTech Ltd shares was Buy at 698.00 on 18 Feb 2014
Read the full article
Data delayed at least 15 minutes, as of Oct 23 2014 12:49 BST.

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Hutchison China MediTech Ltd+4.15%-3.21%+39.08%+78.66%+574.63%
FTSE 100 Index+3.30%-4.13%-4.51%-4.10%+22.09%
Data delayed at least 15 minutes, as of Oct 23 2014 12:49 BST.
© Thomson Reuters Click for restrictions.

All markets data located on is subject to the FT Terms & Conditions.

All content on is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.